ImmunoGen Appoints Stuart A. Arbuckle to Board of Directors

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced the appointment of Stuart A. Arbuckle to its Board of Directors . Mr. Arbuckle is replacing Howard Pien, who is ...
Login to comment.